Coming midterm elections are starting to be framed not as right versus left but instead the ‘well-fed versus the fed-up’

Brian Leeland, a 79-year-old Democratic voter in Detroit, had enough. Frustrated by the way the US media covers this febrile political era, from Donald Trump’s Washington to political campaigns across the country, he contacted the Guardian.

“Your decision to frame the race here as a simple progressive versus establishment choice is overly simplistic verging on lazy,” he wrote to this reporter, after our coverage of progressive Abdul El-Sayed’s campaign in the Democratic US Senate primary in Michigan. “As an electorate, we are not binary for the convenience of the media.”

As the country’s top public health official spends his time in office undermining science, doctors and advocates mount an urgent campaign for childhood vaccines

On an early September morning, dozens of families stood in line outside a clinic in Yeadon, Pennsylvania. It was “exclusion day”, the deadline by which students without complete immunizations are barred from returning to class.

Instead of turning families away, school district leaders partnered with the county health department to vaccinate kids nearby so they could go back to their desks. That day, 42 middle and high school students were vaccinated to protect against tetanus, pertussis and meningitis, among other diseases.

Tobacco investments raise new concerns about Dr Nicole Saphier ahead of confirmation hearing

Donald Trump’s nominee for US surgeon general reported more than $200,000 in business income from a company she owns that sells dietary supplements, a loosely regulated industry that health and consumer advocates say raises concerns about her record and which some critics allege are akin to “snake oil”.

Dr Nicole Saphier, who specializes in breast cancer as a radiologist at Memorial Sloan Kettering Cancer Center in New Jersey and was formerly a Fox News contributor, is facing a Senate confirmation hearing on Wednesday. She filed a financial disclosure and ethics agreement last week.